Published in Turk J Haematol on September 05, 2013
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet (1994) 3.56
Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant (2004) 3.25
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant (2010) 3.05
The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int (2007) 2.10
Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med (1998) 1.80
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Causes of death after renal transplantation. Nephrol Dial Transplant (2001) 1.45
Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis (1995) 1.39
Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.33
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
Viral infection in the renal transplant recipient. J Am Soc Nephrol (2005) 1.29
Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis (1999) 1.09
Beta-herpesvirus challenges in the transplant recipient. J Infect Dis (2002) 1.07
Immunosuppressive effects of beta-herpesviruses. Herpes (2003) 1.03
The changing causes of graft loss and death after kidney transplantation. Transplantation (2002) 1.02
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant (1995) 1.01
Human herpesvirus-6 and -7 in transplantation. Rev Med Virol (2001) 0.99
Twenty and 25 years survival after cadaveric renal transplantation. Transplant Proc (1995) 0.94
Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis (2001) 0.91
The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management. Curr Clin Top Infect Dis (2002) 0.81
Bilateral primary adrenal non-hodgkin lymphoma. Turk J Haematol (2014) 0.78
The Role of Radiotherapy Among the Therapeutic Options for Castleman's Disease. Turk J Haematol (2014) 0.75